Markets:

Overview

News

Currencies

International

Treasuries

ZyVersa Therapeutics, Inc. - Common Stock (NQ:ZVSA)

0.3113 UNCHANGED

Last Price Updated: 4:00 PM EDT, Jul 16, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about ZyVersa Therapeutics, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

ZyVersa Therapeutics Announces IRB Approval of Phase 2a Clinical Trial Protocol to Evaluate Cholesterol Efflux Mediator™ VAR 200 in Patients with Diabetic Kidney Disease

March 18, 2024

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics' CEO, Stephen C. Glover to Participate in a Panel Discussion Titled “Inflammation Illuminated,”at Benzinga’s Virtual Healthcare Summit 2024 on March 20, 2024

March 14, 2024

From ZyVersa Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

March 07, 2024

Via Benzinga

ZyVersa Therapeutics Generated Approximately $2.7 Million From Exercise of Warrants Following Excitement Around News That Inflammasome Inhibitors Have Potential to Effectively Treat Obesity

February 29, 2024

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics Highlights Data from Review Article Published in Nature Reinforcing IC 100’s Rationale for Inhibiting ASC and ASC Specks to Attenuate Damaging Inflammation Associated with Various Conditions, Including Obesity and Its Complications

February 28, 2024

From ZyVersa Therapeutics

Via GlobeNewswire

Why TransMedics Group Shares Are Trading Higher By Around 23%; Here Are 20 Stocks Moving Premarket ↗

February 27, 2024

Shares of TransMedics Group, Inc. (NASDAQ: TMDX) rose sharply in today’s pre-market trading after the company reported better-than-expected fourth-quarter financial results and issued strong guidance.

Via Benzinga

Why Freshpet Shares Are Trading Higher By Around 15%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

February 26, 2024

Shares of Freshpet, Inc. (NASDAQ: FRPT) gained 15.5% to $106.29 after the company reported better-than-expected fourth-quarter financial results.

Via Benzinga

12 Health Care Stocks Moving In Monday's Intraday Session ↗

February 26, 2024

Via Benzinga

What In The World Is Going On With ZyVersa Therapeutics (ZVSA) Stock? ↗

February 26, 2024

ZyVersa Therapeutics shares are trading higher by 126% Monday. The stock continues to be volatile after the company last week released a white paper.

Via Benzinga

US Stocks Edge Higher; Domino's Posts Upbeat Earnings ↗

February 26, 2024

U.S. stocks traded mostly higher this morning, with the Nasdaq Composite gaining around 50 points on Monday. Following the market opening Monday, the Dow traded up 0.04% 39,148.74 while the NASDAQ rose...

Via Benzinga

Topics Stocks

Why Is Intuitive Machines (LUNR) Stock Down 23% Today? ↗

February 26, 2024

Intuitive Machines stock is falling on Monday as investors in LUNR react to an update on the company's lunar landing last week.

Via InvestorPlace

Why Is Aclarion (ACON) Stock Down 19% Today? ↗

February 26, 2024

Aclarion stock is falling on Monday as investors react to news of a public offering for shares of ACON and a delisting update.

Via InvestorPlace

Why Is Freight Technologies (FRGT) Stock Up 25% Today? ↗

February 26, 2024

Freight Technologies stock is heading higher on Monday with heavy trading of FRGT alongside a collaboration deal with Envases Universales.

Via InvestorPlace

Why Intuitive Machines Shares Are Trading Lower By Around 30%; Here Are 20 Stocks Moving Premarket ↗

February 26, 2024

Shares of Intuitive Machines, Inc. (NASDAQ: LUNR) fell sharply in today’s pre-market trading. Intuitive Machines revealed Friday that its lunar lander, Odysseus, encountered a mishap during a touchdown...

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

February 26, 2024

Via Benzinga

Why Is ZyVersa Therapeutics (ZVSA) Stock Up 37% Today? ↗

February 26, 2024

ZyVersa Therapeutics stock is rising higher on Monday as shares of ZVDA experience heavy pre-market trading this morning.

Via InvestorPlace

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday ↗

February 26, 2024

We're starting the trading week with a breakdown of the biggest pre-market stock movers traders need to know about on Monday morning!

Via InvestorPlace

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 23, 2024

Via Benzinga

ZyVersa Therapeutics Publishes New White Paper Detailing the Role of Inflammasomes and ASC Specks in Neurological Diseases, and Data Supporting Inflammasome ASC Inhibitor IC 100 as a Potential Therapeutic Option

February 22, 2024

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics Highlights Review Article Substantiating That Inflammasome Activation Is Pathogenic in Multiple Neurological Diseases

February 14, 2024

From ZyVersa Therapeutics

Via GlobeNewswire

12 Health Care Stocks Moving In Friday's After-Market Session ↗

February 09, 2024

Via Benzinga

ZyVersa Therapeutics' CEO, Stephen C. Glover to Present at the 2024 BIO CEO & Investor Conference to Provide Corporate Update and Discuss Key Milestones

February 07, 2024

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics Highlights Publication Indicating That Inflammasome NLRP3-Mediated Inflammation in Obese Children Leads to Insulin Resistance and Risk of Complications Such as Type 2 Diabetes

January 31, 2024

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics Announces Peer-Reviewed Article Supporting the Therapeutic Potential of Targeting ASC Specks During Progression of Alzheimer’s Disease

January 24, 2024

From ZyVersa Therapeutics

Via GlobeNewswire

Why KeyCorp Shares Are Trading Lower By Over 5%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗

January 18, 2024

Shares of KeyCorp (NYSE: KEY) moved lower during Thursday’s session after the company reported fourth-quarter financial results. Revenues of $1.538 billion, down 19.0% Y/Y, slightly topped the...

Via Benzinga

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

January 18, 2024

Via Benzinga

Why Is Inflammatory Disease-Focused ZyVersa Therapeutics Stock Trading Higher Today? ↗

January 17, 2024

ZyVersa reveals study in Acta Neuropathologica Communications. Learn how inhibiting NLRP3 inflammasome with Inflammasome ASC Inhibitor IC 100 prevents TNBC brain metastasis.

Via Benzinga

12 Health Care Stocks Moving In Wednesday's Pre-Market Session ↗

January 17, 2024

Via Benzinga

ZyVersa Therapeutics Highlights Peer-Reviewed Article Linking Inflammasome Activation to Triple-Negative Breast Cancer Brain Metastasis

January 17, 2024

From ZyVersa Therapeutics

Via GlobeNewswire

ZyVersa Therapeutics’ CEO, Stephen C. Glover, Featured on Benzinga All Access

January 10, 2024

From ZyVersa Therapeutics

Via GlobeNewswire

< Previous 1 2 3 4 5 6 7 8 9 10 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.